[Significance of quantum chemical interactions for medicinal science and design of β-secretase inhibitors]
- PMID: 23832586
- DOI: 10.1248/yakushi.13-00179
[Significance of quantum chemical interactions for medicinal science and design of β-secretase inhibitors]
Abstract
This review discusses the importance of quantum chemical interactions in biomolecules for medicinal science and their relevance to the author's β-secretase (BACE1) inhibitor drug discovery research. Although molecular mechanics/dynamics (MM/MD) methods are available in many in silico design tools used for drug discovery, they cannot accurately evaluate quantum effects between biomolecules and drugs. The key roles of biomolecular quantum chemical interactions in drug discovery are discussed using the arginine side chain as an example. Arginine is recognized as a charged amino acid in commonly used drug design software, unlike other amino acids with π-electron orbitals, such as phenylalanine, tyrosine, and tryptophan. Quantum chemical interactions via the arginine side chain are crucial for molecular recognition, and are found in many X-ray crystal structures, such as protein-protein, protein homodimer, RNA aptamer-protein, and enzyme-inhibitor complexes. This review describes the essential role of quantum chemical interactions via the arginine side chain in the mechanism of BACE1 inhibition, and proposes an "electron donor/acceptor bioisostere" concept for medicinal science based on quantum chemical interactions. Several potent BACE1 inhibitors, as well as the first peptides with BACE1 inhibiting activity were designed and synthesized based on studies of quantum chemical interactions via arginine side chain and the "electron donor bioisostere" concept.
Similar articles
-
Advances in the identification of β-secretase inhibitors.Expert Opin Drug Discov. 2013 Jun;8(6):709-31. doi: 10.1517/17460441.2013.784267. Epub 2013 Apr 9. Expert Opin Drug Discov. 2013. PMID: 23565721 Review.
-
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.Bioorg Med Chem Lett. 2010 Jan 15;20(2):632-5. doi: 10.1016/j.bmcl.2009.11.052. Epub 2009 Nov 20. Bioorg Med Chem Lett. 2010. PMID: 19959359
-
Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.J Biomol Struct Dyn. 2016;34(2):239-49. doi: 10.1080/07391102.2015.1022603. Epub 2015 Apr 9. J Biomol Struct Dyn. 2016. PMID: 25707809
-
Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach.J Mol Graph Model. 2017 Sep;76:56-69. doi: 10.1016/j.jmgm.2017.06.001. Epub 2017 Jun 8. J Mol Graph Model. 2017. PMID: 28710924
-
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.Expert Opin Investig Drugs. 2017 Oct;26(10):1131-1136. doi: 10.1080/13543784.2017.1369527. Epub 2017 Aug 23. Expert Opin Investig Drugs. 2017. PMID: 28817311 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous